HuGE Literature Finder
Records
1
-
8
Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
Coding SNPs in hsa-miR-1343-3p and hsa-miR-6783-3p target sites of CYP2C19 modulates clopidogrel response in individuals with cardiovascular diseases. Life sciences 2020 Jan 245 117364. Sharma Anu Radha, Vohra Manik, Shukla Vaibhav, Guddattu Vasudeva, Razak Uk Abdul, Shetty Ranjan, Umakanth Shashikiran, Satyamoorthy Kapaettu, Rai Padmalatha |
[CLINICAL AND PHARMACOLOGICAL FACTORS INFLUENCING RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH CARDIOVASCULAR DISEASES]. Klinicheskaia meditsina 2015 93 (2): 40-6. Mesitskaia D F, Nikitina Iu M, Kopylov F Iu, Syrkin A L, Aksenova M G, Kirillov M Iu, Dobrovol'ski? A |
The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases. Journal of clinical pharmacology 2014 Aug 54 (8): 874-80. Kara?niewicz-?ada Marta, Danielak Dorota, Rubi? B?a?ej, Burchardt Pawe?, Oszkinis Grzegorz, G?ówka Francisz |
Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. Frontiers in genetics 2012 3 . Roco A, Quiñones L, Agúndez JA, García-Martín E, Squicciarini V, Miranda C, Garay J, Farfán N, Saavedra I, Cáceres D, Ibarra C, Varela N |
Relationship between cytochrome P450 2C19*17 genotype distribution, platelet aggregation and bleeding risk in patients with blood stasis syndrome of coronary artery disease treated with clopidogrel. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 2012 Jun 10 (6): 647-54. Dai Ze-long, Chen Hui, Wu Xiao-yi |
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. European heart journal 2012 Mar . Bhatt DL, Paré G, Eikelboom JW, Simonsen KL, Emison ES, Fox KA, Steg PG, Montalescot G, Bhakta N, Hacke W, Flather MD, Mak KH, Cacoub P, Creager MA, Berger PB, Steinhubl SR, Murugesan G, Mehta SR, Kottke-Marchant K, Lincoff AM, Topol EJ |
Effects of omeprazole and genetic polymorphism of CYP2C19 on the clopidogrel active metabolite. Drug metabolism and disposition: the biological fate of chemicals 2012 Jan 40 (1): 187-97. Boulenc Xavier, Djebli Nassim, Shi Juan, Perrin Laurent, Brian William, Van Horn Robert, Hurbin Fabri |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 06, 2022
- Content source: